Alvion Pharmaceuticals

Alvion is a Greece-based pharmaceutical company with a strong international orientation, focused on the development of generics and value-added, IP-driven medicines across key therapeutic areas. The company is committed to delivering the right drug, at the right place, at the right time, by leveraging deep scientific expertise, regulatory excellence, and a customer-centric B2B approach.

Alvion has rapidly built a strong track record in the development of high-value, differentiated generic medicines, supported by an experienced management team with extensive R&D specialization and commercial know-how, as well as long-standing, trusted relationships across the global pharmaceutical industry.

With a scalable, light-asset operating model and a growing international footprint, Alvion is strategically positioned to expand its development platform and progress toward its long-term ambition of becoming a vertically integrated pharmaceutical company by 2030.